These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 14670128)

  • 1. Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin.
    Brown AB; Yang W; Schmidt NO; Carroll R; Leishear KK; Rainov NG; Black PM; Breakefield XO; Aboody KS
    Hum Gene Ther; 2003 Dec; 14(18):1777-85. PubMed ID: 14670128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas.
    Aboody KS; Brown A; Rainov NG; Bower KA; Liu S; Yang W; Small JE; Herrlinger U; Ourednik V; Black PM; Breakefield XO; Snyder EY
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12846-51. PubMed ID: 11070094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells.
    Lee DH; Ahn Y; Kim SU; Wang KC; Cho BK; Phi JH; Park IH; Black PM; Carroll RS; Lee J; Kim SK
    Clin Cancer Res; 2009 Aug; 15(15):4925-34. PubMed ID: 19638465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression.
    Kim SK; Kim SU; Park IH; Bang JH; Aboody KS; Wang KC; Cho BK; Kim M; Menon LG; Black PM; Carroll RS
    Clin Cancer Res; 2006 Sep; 12(18):5550-6. PubMed ID: 17000692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human neural stem cells transduced with IFN-beta and cytosine deaminase genes intensify bystander effect in experimental glioma.
    Ito S; Natsume A; Shimato S; Ohno M; Kato T; Chansakul P; Wakabayashi T; Kim SU
    Cancer Gene Ther; 2010 May; 17(5):299-306. PubMed ID: 19893595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel method for visualizing and modeling the spatial distribution of neural stem cells within intracranial glioma.
    Lin D; Najbauer J; Salvaterra PM; Mamelak AN; Barish ME; Garcia E; Metz MZ; Kendall SE; Bowers M; Kateb B; Kim SU; Johnson M; Aboody KS
    Neuroimage; 2007; 37 Suppl 1():S18-26. PubMed ID: 17560798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.
    Aboody KS; Najbauer J; Metz MZ; D'Apuzzo M; Gutova M; Annala AJ; Synold TW; Couture LA; Blanchard S; Moats RA; Garcia E; Aramburo S; Valenzuela VV; Frank RT; Barish ME; Brown CE; Kim SU; Badie B; Portnow J
    Sci Transl Med; 2013 May; 5(184):184ra59. PubMed ID: 23658244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma.
    Shimato S; Natsume A; Takeuchi H; Wakabayashi T; Fujii M; Ito M; Ito S; Park IH; Bang JH; Kim SU; Yoshida J
    Gene Ther; 2007 Aug; 14(15):1132-42. PubMed ID: 17508009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model.
    Thu MS; Najbauer J; Kendall SE; Harutyunyan I; Sangalang N; Gutova M; Metz MZ; Garcia E; Frank RT; Kim SU; Moats RA; Aboody KS
    PLoS One; 2009 Sep; 4(9):e7218. PubMed ID: 19787043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural Stem Cell-Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients.
    Portnow J; Synold TW; Badie B; Tirughana R; Lacey SF; D'Apuzzo M; Metz MZ; Najbauer J; Bedell V; Vo T; Gutova M; Frankel P; Chen M; Aboody KS
    Clin Cancer Res; 2017 Jun; 23(12):2951-2960. PubMed ID: 27979915
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined treatment of tumor-tropic human neural stem cells containing the CD suicide gene effectively targets brain tumors provoking a mild immune response.
    Lee SJ; Kim Y; Jo MY; Kim HS; Jin Y; Kim SU; Jin J; Joo KM; Nam DH
    Oncol Rep; 2011 Jan; 25(1):63-8. PubMed ID: 21109958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural stem cell-mediated delivery of irinotecan-activating carboxylesterases to glioma: implications for clinical use.
    Metz MZ; Gutova M; Lacey SF; Abramyants Y; Vo T; Gilchrist M; Tirughana R; Ghoda LY; Barish ME; Brown CE; Najbauer J; Potter PM; Portnow J; Synold TW; Aboody KS
    Stem Cells Transl Med; 2013 Dec; 2(12):983-92. PubMed ID: 24167321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effect of genetically modified human neural stem cells encoding cytosine deaminase on experimental glioma.
    Kim JH; Kim JY; Kim SU; Cho KG
    Biochem Biophys Res Commun; 2012 Jan; 417(1):534-40. PubMed ID: 22177952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VP22 and cytosine deaminase fusion gene modified tissue-engineered neural stem cells for glioma therapy.
    Jin G; Zhou Y; Chai Q; Zhu G; Xu F; Liu F
    J Cancer Res Clin Oncol; 2013 Mar; 139(3):475-83. PubMed ID: 23180018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine potentiates the therapeutic effects of neural stem cells expressing cytosine deaminase against metastatic brain tumors.
    Kang W; Seol HJ; Seong DH; Kim J; Kim Y; Kim SU; Nam DH; Joo KM
    Oncol Rep; 2013 Sep; 30(3):1101-6. PubMed ID: 23828015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells.
    Yi BR; Hwang KA; Kang NH; Kim SU; Jeung EB; Kim HC; Choi KC
    Cancer Gene Ther; 2012 Sep; 19(9):644-51. PubMed ID: 22790964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural stem cell tropism to glioma: critical role of tumor hypoxia.
    Zhao D; Najbauer J; Garcia E; Metz MZ; Gutova M; Glackin CA; Kim SU; Aboody KS
    Mol Cancer Res; 2008 Dec; 6(12):1819-29. PubMed ID: 19074827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma.
    Yuan X; Hu J; Belladonna ML; Black KL; Yu JS
    Cancer Res; 2006 Mar; 66(5):2630-8. PubMed ID: 16510582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural stem cell-based dual suicide gene delivery for metastatic brain tumors.
    Wang C; Natsume A; Lee HJ; Motomura K; Nishimira Y; Ohno M; Ito M; Kinjo S; Momota H; Iwami K; Ohka F; Wakabayashi T; Kim SU
    Cancer Gene Ther; 2012 Nov; 19(11):796-801. PubMed ID: 23018623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases.
    Joo KM; Park IH; Shin JY; Jin J; Kang BG; Kim MH; Lee SJ; Jo MY; Kim SU; Nam DH
    Mol Ther; 2009 Mar; 17(3):570-5. PubMed ID: 19127251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.